Enanta Pharmaceuticals has a total of 1607 patents globally, out of which 619 have been granted. Of these 1607 patents, more than 49% patents are active. The United States of America is where Enanta Pharmaceuticals has filed the maximum number of patents, followed by Europe and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Enanta Pharmaceuticals.
Enanta Pharmaceuticals was founded in 1995. Enanta Pharmaceuticals Inc operates as a biotechnology company. The Company focuses on research, development, and creation of small molecule drugs for viral infections and liver diseases. As of August 2022, Enanta Pharmaceuticals has a market cap of $ 1.242 Billion.
Do read about some of the most popular patents of Enanta Pharmaceuticals which have been covered by us in this article and also you can find Enanta Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Enanta Pharmaceuticals patent portfolio.
How many patents does the CEO of Enanta Pharmaceuticals have?
The CEO, Dr. Jay Luly, has 279 patents.
How many patents does Enanta Pharmaceuticals have?
Enanta Pharmaceuticals has a total of 1607 patents globally. These patents belong to 330 unique patent families. Out of 1607 patents, 792 patents are active.
How Many Patents did Enanta Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Enanta Pharmaceuticals Applications Filed | Enanta Pharmaceuticals Patents Granted |
| 2011 | 130 | 12 |
| 2012 | 54 | 29 |
| 2013 | 42 | 40 |
| 2014 | 50 | 92 |
| 2015 | 75 | 52 |
| 2016 | 75 | 44 |
| 2017 | 112 | 24 |
| 2018 | 138 | 28 |
| 2019 | 90 | 35 |
| 2020 | 68 | 46 |
| 2021 | 60 | 69 |
| 2022 | 7 | 37 |
How many Enanta Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Enanta Pharmaceuticals File in Different Countries?
Countries in which Enanta Pharmaceuticals Filed Patents
| Country | Patent |
| United States Of America | 331 |
| Europe | 74 |
| Australia | 73 |
| China | 66 |
| Japan | 65 |
| Canada | 56 |
| Hong Kong (S.A.R.) | 56 |
| Korea (South) | 49 |
| Mexico | 44 |
| India | 41 |
| Brazil | 36 |
| Taiwan | 33 |
| Singapore | 30 |
| Israel | 29 |
| Philippines | 24 |
| Indonesia | 23 |
| Argentina | 22 |
| Germany | 20 |
| New Zealand | 20 |
| Malaysia | 20 |
| Uruguay | 18 |
| Russia | 17 |
| Chile | 17 |
| Spain | 15 |
| South Africa | 15 |
| Peru | 13 |
| Pakistan | 13 |
| Viet Nam | 13 |
| Norway | 11 |
| Colombia | 11 |
| Portugal | 10 |
| Mongolia | 10 |
| Denmark | 10 |
| Croatia | 9 |
| Slovenia | 9 |
| Poland | 9 |
| Eurasia | 8 |
| Ecuador | 8 |
| Cyprus | 8 |
| Malta | 8 |
| Costa Rica | 7 |
| Lithuania | 5 |
| Hungary | 5 |
| Dominican Republic | 4 |
| Macao | 4 |
| Africa | 4 |
| Serbia | 3 |
| Guatemala | 3 |
| Netherlands | 2 |
| Bolivia | 2 |
| Austria | 2 |
| Albania | 2 |
| Bangladesh | 2 |
| Luxembourg | 2 |
| San Marino | 1 |
| North Macedonia | 1 |
| Morocco | 1 |
| Tunisia | 1 |
| Cuba | 1 |
| Turkey | 1 |
| Gulf Cooperation Council | 1 |
| Kenya | 1 |
Where are Research Centers of Enanta Pharmaceuticals Patents Located?
10 Best Enanta Pharmaceuticals Patents
WO2005010029A1 is the most popular patent in the Enanta Pharmaceuticals portfolio. It has received 259 citations so far from companies like Tibotec Pharmaceuticals, Intermune, Bristol-Myers Squibb.
Below is the list of 10 most cited patents of Enanta Pharmaceuticals:
| Publication Number | Citation Count |
| WO2005010029A1 | 259 |
| WO2010099527A1 | 248 |
| WO2010091413A1 | 175 |
| WO2010096462A1 | 174 |
| US7176208B2 | 130 |
| WO2011031934A1 | 120 |
| WO2010148006A1 | 114 |
| WO2011031904A1 | 108 |
| WO2009003009A1 | 101 |
| WO2008022006A2 | 101 |
Which Companies are using Enanta Pharmaceuticals Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the Enanta Pharmaceuticals patent portfolio are Abbvie, Bristol-Myers Squibb and S&T Global.
List of the top forward citing Companies –
| Company | Number of Patents |
| Abbvie Inc | 34 |
| Bristol-Myers Squibb | 5 |
| S&T Global Inc | 3 |
| Novartis | 2 |
| Janssen Sciences Ireland Uc | 2 |
| Abbvie Deutschland Gmbh & Co Kg | 2 |
| Vertex Pharmaceuticals | 4 |
| Wockhardt | 2 |
| Ourofino Animal Health | 1 |
| Tetard Inc | 1 |
Count of 102 and 103 Type Rejections based on Enanta Pharmaceuticals Patents
Top Enanta Pharmaceuticals Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US8648037B2 | 16 |
| US8420596B2 | 11 |
| US8101643B2 | 9 |
| US8575119B2 | 3 |
| US8367618B2 | 3 |
| US8420686B2 | 2 |
| US20090209547A1 | 2 |
| US9156818B2 | 2 |
| US7176208B2 | 2 |
| US8822700B2 | 2 |
| US20090075915A1 | 2 |
| US7635683B2 | 2 |
| US10519191B2 | 1 |
| US8927709B2 | 1 |
| US8785377B2 | 1 |
What Percentage of Enanta Pharmaceuticals US Patent Applications were Granted?
Enanta Pharmaceuticals (Excluding its subsidiaries) has filed 303 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 208 have been granted leading to a grant rate of 79.39%.
Below are the key stats of Enanta Pharmaceuticals patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Enanta Pharmaceuticals?
| Law Firm | Total Applications | Success Rate |
| Elmore Patent Law Group Pc | 262 | 80.87% |
| Locke Lord Llp | 15 | 75.00% |
| Foley Hoag | 11 | 90.91% |
| Enanta Pharmaceuticals Inc | 10 | 28.57% |
| Nelson Mullins Riley & Scarborough | 2 | 0.00% |
| Fish & Richardson P C Bo | 1 | 0.00% |
| Ibm Corporation | 1 | 100.00% |
| Nada Jain | 1 | 0.00% |
EXCLUSIVE INSIGHTS COMING SOON!
What are Enanta Pharma’s key innovation segments?
What Technologies are Covered by Enanta Pharma’s?
The chart below distributes patents filed by Enanta Pharma’s in different countries on the basis of the technology protected in patents. It also represents the markets where Enanta Pharma’s thinks it’s important to protect particular technology inventions.
R&D Focus: How Enanta Pharma’s search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Enanta Pharma’s?